Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 28, 2011
Complaint involves Guidant's conduct leading to its recalls of ICDs in 2005, before Boston Scientific’s 2006 acquisition of Guidant
-
Jan 27, 2011
Procedure performed as part of BLOCk-CTI clinical trial evaluating treatment of Type 1 atrial flutter
-
Jan 26, 2011
PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent
-
Jan 24, 2011
Fourth-generation stent features bioabsorbable polymer and everolimus drug coating
-
Jan 19, 2011
Distribution agreement will allow Company to expand the service it offers customers in Japan
-
Jan 19, 2011
A live webcast and archived replay of this call will be available
-
Jan 19, 2011
Innovative left atrial appendage closure device offers alternative for patients with atrial fibrillation and strengthens Company's position in emerging structural heart markets
-
Jan 10, 2011
ORION clinical trial designed to evaluate EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease
-
Jan 5, 2011Innovative technology designed to advance deep brain stimulation therapy
Boston Scientific Corporation (NYSE: BSX) today announced it has acquired Intelect Medical, Inc., a development-stage company located in...
-
Jan 4, 2011
Article reported on a study that found about 20 percent of patients who received an implantable cardioverter defibrillator (ICD) did not meet evidence-based guidelines